Maria Geffken

985 total citations
24 papers, 593 citations indexed

About

Maria Geffken is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Maria Geffken has authored 24 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Maria Geffken's work include CAR-T cell therapy research (4 papers), Connective Tissue Growth Factor Research (4 papers) and Wound Healing and Treatments (4 papers). Maria Geffken is often cited by papers focused on CAR-T cell therapy research (4 papers), Connective Tissue Growth Factor Research (4 papers) and Wound Healing and Treatments (4 papers). Maria Geffken collaborates with scholars based in Germany, Austria and United States. Maria Geffken's co-authors include Klaus Pantel, Volkmar Müller, Simon A. Joosse, Sven Peine, Martin Sebastian Winkler, Edzard Schwedhelm, Fabian Trillsch, Heidi Schwarzenbach, Sven� Mahner and Xiaodan Meng and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Maria Geffken

23 papers receiving 587 citations

Peers

Maria Geffken
Subhash Haldar United States
Patryk Moskwa United States
Xiao Hu China
Yu Zeng China
Maria Geffken
Citations per year, relative to Maria Geffken Maria Geffken (= 1×) peers Helga Schachner

Countries citing papers authored by Maria Geffken

Since Specialization
Citations

This map shows the geographic impact of Maria Geffken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Geffken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Geffken more than expected).

Fields of papers citing papers by Maria Geffken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Geffken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Geffken. The network helps show where Maria Geffken may publish in the future.

Co-authorship network of co-authors of Maria Geffken

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Geffken. A scholar is included among the top collaborators of Maria Geffken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Geffken. Maria Geffken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartkowiak, Kai, Stefan Werner, Antje Andreas, et al.. (2025). Discovery of a sushi domain-containing protein 2-positive phenotype in circulating tumor cells of metastatic breast cancer patients. Scientific Reports. 15(1). 3913–3913. 2 indexed citations
2.
Smeets, Ralf, et al.. (2025). Effect of Mouth Rinsing and Antiseptic Solutions on Periodontitis Bacteria in an In Vitro Oral Human Biofilm Model. Dentistry Journal. 13(7). 324–324. 1 indexed citations
3.
Geffken, Maria, et al.. (2024). Iron transport pathways in the human malaria parasite Plasmodium falciparum revealed by RNA-sequencing. Frontiers in Cellular and Infection Microbiology. 14. 1480076–1480076. 1 indexed citations
4.
Brill, Florian H. H., Maria Geffken, Julian‐Dario Rembe, et al.. (2023). Quantitative Insights and Visualization of Antimicrobial Tolerance in Mixed-Species Biofilms. Biomedicines. 11(10). 2640–2640. 3 indexed citations
5.
Fehse, Boris, Nuray Akyüz, Maria Geffken, et al.. (2022). Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy. Haematologica. 108(2). 444–456. 14 indexed citations
6.
Brill, Florian H. H., et al.. (2022). Pulsed low-intensity laser treatment stimulates wound healing without enhancing biofilm development in vitro. Journal of Photochemistry and Photobiology B Biology. 233. 112504–112504. 7 indexed citations
7.
Stuermer, Ewa K., Florian H. H. Brill, Maria Geffken, et al.. (2021). In vitro Activity of Antimicrobial Wound Dressings on P. aeruginosa Wound Biofilm. Frontiers in Microbiology. 12. 664030–664030. 14 indexed citations
8.
Casjens, Swaantje, Antje Andreas, Thomas Brüning, et al.. (2021). Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study. Molecular Oncology. 15(11). 2877–2890. 9 indexed citations
9.
Stuermer, Ewa K., Florian H. H. Brill, Maria Geffken, et al.. (2021). Comparative analysis of biofilm models to determine the efficacy of antimicrobials. International Journal of Hygiene and Environmental Health. 234. 113744–113744. 15 indexed citations
10.
Bartkowiak, Kai, Isabel Heidrich, Marcel Kwiatkowski, et al.. (2021). Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells. Cancers. 13(3). 563–563. 9 indexed citations
11.
Ayuk, Francis, Carolina Berger, Anita Badbaran, et al.. (2021). Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting. Blood Advances. 5(11). 2523–2527. 27 indexed citations
12.
Fehse, Boris, Anita Badbaran, Carolina Berger, et al.. (2020). Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel. Molecular Therapy — Methods & Clinical Development. 16. 172–178. 43 indexed citations
13.
Klyuchnikov, Evgeny, Maximilian Christopeit, Francis Ayuk, et al.. (2020). Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression. Bone Marrow Transplantation. 55(9). 1817–1820.
14.
Daum, Günter, Martin Sebastian Winkler, Eileen Moritz, et al.. (2020). Determinants of Serum- and Plasma Sphingosine-1-Phosphate Concentrations in a Healthy Study Group. SHILAP Revista de lepidopterología. 4(1). e12–e19. 18 indexed citations
15.
Badbaran, Anita, Carolina Berger, Kristoffer Riecken, et al.. (2020). Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR. Cancers. 12(7). 1970–1970. 23 indexed citations
16.
Moritz, Eileen, Maria Geffken, Joerg Schreiber, et al.. (2019). Analyses of sphingosine‐1‐phosphate in the context of transfusion: how much is in stored blood products and in patient blood?. Transfusion. 59(10). 3071–3076. 7 indexed citations
17.
Geissen, Markus, Edzard Schwedhelm, Martin Sebastian Winkler, et al.. (2016). Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans. PLoS ONE. 11(12). e0168302–e0168302. 44 indexed citations
18.
Babayan, Anna, Malik Alawi, Michael Gormley, et al.. (2016). Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells. Oncotarget. 8(34). 56066–56080. 56 indexed citations
19.
Winkler, Martin Sebastian, Axel Nierhaus, Maria Geffken, et al.. (2015). Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Critical Care. 19(1). 372–372. 96 indexed citations
20.
Meng, Xiaodan, Simon A. Joosse, Volkmar Müller, et al.. (2015). Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. British Journal of Cancer. 113(9). 1358–1366. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026